Background Transjugular intrahepatic portosystemic shunt (TIPS) has proven clinical efficacy as rescue therapy for cirrhotic patients with acute portal hypertensive bleeding who fail endoscopic treatment. Aims To investigate predictive factors of 6-week and 1-year mortality in patients undergoing salvage TIPS for refractory portal hypertensive bleeding. Methods A total of 144 consecutive patients were retrospectively evaluated. Three logistic regression multivariate models were estimated to individualize prognostic factors for 6-week and 12-month mortality. Log-rank test was used to evaluate survival according to Child-Pugh classes and Bureau's criteria.
Introduction
Transjugular intrahepatic portosystemic shunt (TIPS) is a radiological procedure widely used to treat complications of portal hypertension [1] . This procedure was introduced 35 years ago as a substitute for surgical shunts to avoid operative mortality and possibly reduce encephalopathy rates [2] . Only three indications for TIPS have been evaluated in randomized clinical trials: secondary prophylaxis of variceal bleeding, treatment of acute variceal bleeding and refractory/resistant ascites [3] [4] [5] . Other indications for TIPS include hepatic hydrothorax, Budd-Chiari syndrome, veno-occlusive disease, portal vein thrombosis, hepatopulmonary and hepatorenal syndrome [6] . The procedure can be complicated by thrombosis/occlusion, and stent migration, but the use of polytetrafluoroethylene (PTFE)-covered stents has reduced the incidence of such technical and mechanical complications [7] [8] [9] .
There are several prognostic models for patients undergoing TIPS for variceal bleeding, but there are only few robust predictors of mortality, such as high bilirubin levels and higher Child-Pugh (class C) [10, 11] . Recently, the Mayo Clinic mathematical model for end-stage liver disease (MELD) has been developed to predict early mortality after elective TIPS [12] , but only a retrospective study has evaluated the model in emergency TIPS [13] . In patients with refractory ascites treated with TIPS, the combination of a bilirubin level below 50 μmol/L (3 mg/ dl) and a platelet count above 75 × 10 9 /L is predictive of survival [14] .
TIPS has proven clinical efficacy as salvage therapy for cirrhotic patients with acute portal hypertensive bleeding (PHB) that fail endoscopic and/or pharmacological therapy. Early mortality in this high-risk group is about 50% [15] . A recent trial in patients with cirrhosis and acute variceal bleeding at high risk for treatment failure demonstrated that the early use of TIPS was associated with a significant improvement in survival [3] .
Our first aim was to evaluate prognostic variables in relation to mortality in consecutive patients who had salvage TIPS for refractory portal hypertensive bleeding and to assess whether MELD score, which has been derived from cohorts undergoing elective TIPS, maintains the same accuracy in the stratification of risk for patients undergoing salvage TIPS. Secondly, we evaluated the variables associated with TIPS failure (defined as re-bleeding within 6 weeks from the procedure) [16] and 6-week and 12-month survival.
Patients and Methods
We evaluated 144 consecutive patients with cirrhosis who underwent salvage TIPS for acute portal hypertensive bleeding refractory to standard endoscopic treatment at the Royal Free Sheila Sherlock Liver Unit from June 1992 to May 2008. Salvage TIPS was defined as TIPS procedure performed after at least two unsuccessful endoscopic attempts to control portal hypertensive bleeding [15] . Data were collected prospectively in a database, which was then analyzed retrospectively. Epidemiological and laboratory factors (gender, age, bilirubin, albumin, sodium, international normalized ratio (INR), creatinine, white blood cells, aspartate aminotransferase (AST), alanine aminotransferase (ALT), hemoglobin, platelets), pre-TIPS Child-Pugh score (CPS), MELD score, MELD-Na, as well as portal pressure gradient (PPG) before and after TIPS, number of blood units transfused (RBCs), length of intensive care unit stay (ITUs) before TIPS, need of mechanical ventilation (MV), the presence of ascites or hepatic encephalopathy (HE), type of stent inserted (uncovered vs. PTFE-coated), time from admission to TIPS procedure (< 24 h, 24-72 h, > 72 h), and Bureau's criteria [a combination of platelet count above 75x10 9 /L and a bilirubin level lower than 50 μmol/L (3 mg/dl)] [14] were recorded.
Criteria for TIPS use were based on failure to control bleeding with endoscopic therapy and vasoactive drugs. These conformed in essence to the Baveno IV criteria [16] .
TIPS insertion was preferably performed within 72 h after endoscopy, and vasoactive drugs were administered until TIPS placement. Since 2000, all patients also received prophylactic antibiotic therapy. Child-Pugh class stratification was performed as follows: score of 5-9 (CP-A/B) and score of 10-15 (CP-C).
Before the TIPS procedure, patients underwent a routine electrocardiography, computed tomography of the abdomen and/or Doppler ultrasound of the liver portal venous system, and routine laboratory tests.
TIPS Procedure
TIPS insertion was performed in the interventional radiology suite after obtaining a signed informed consent by the patients or their relatives. TIPS procedure was executed as previously described [17] . Variceal embolization was also performed to occlude the filling of large collaterals feeding gastroesophageal varices and maximize the flow to the liver [18] . PTFE-coated stents were used since 2002 [19] .
The target value of portal pressure gradient was 12 mmHg or, alternatively, a reduction of at least 20% from the baseline [20] . However, all efforts were made to maintain the shunt diameter as small as possible in order to avoid the risk of severe encephalopathy, particularly in patients who had already experienced this complication. Thus, the final diameter of the shunt and the reduction of the portal pressure were left to a decision of operator, either a hepatologist or a liver radiologist who worked in combination.
Statistical Analysis
Data are presented as mean ± standard deviation or median and range values for numerical variables with parametric and nonparametric distributions, respectively, and as percentage for categorical variables. Statistical analysis was performed using t test, ANOVA, Mann-Whitney test or Kruskal-Wallis test for comparisons of continuous variables between or among groups, corrected Chi-squared method or two-tailed Fisher's exact test for comparisons of qualitative data, and Spearman's coefficient for correlations of quantitative data, when appropriate. Multivariate analysis was performed using logistic regression models. Data were censored at the time of the last contact with the patient, liver transplantation or death. Predictive variables for re-bleeding rate at 6 weeks as well as 6-week and 12-month mortalities were assessed by binary logistic regression [providing odds ratio (OR), relative 95% confidence interval (95% CI) and p value]. In order to individualize the main prognostic factors for short-term (6 weeks) and long-term (12 months) mortalities, we performed different logistic regression models. The multivariate model included the variables significant at the univariate approach (significance level p < 0.05) and also the time from bleeding to TIPS procedure and the type of stent used (covered vs. uncovered). Twelve-month mortality was described by the Kaplan-Meier curve, stratifying the patients according to Child-Pugh class. Log-rank test was applied to evaluate significant differences in the survival function in the above-mentioned classes (CP-A/B and CP-C, respectively). All significance tests were two-sided, and p values < 0.05 were considered statistically significant. Data processing and analyses were performed by SPSS for Windows (version 22.0, IBM, New York, NY, USA).
Results

Study Patients
Baseline patients' characteristics are summarized in Table 1 . Mean age was 51 ± 10.7 years, with male predominance (n = 95, 66%). The etiology of liver disease was alcohol, viral, nonalcoholic fatty liver disease (NAFLD) and autoimmune/cryptogenic in 83 (57.6%), 20 (13.9%), 14 (9.7%), and 27 (18.8%) cases, respectively. The majority of patients (71%) were referred from other hospitals. One hundred and fourteen (79%) patients bled from esophageal varices, while in 30 patients the source of bleeding was gastric varices. The endoscopic treatment for esophageal varices was sclerotherapy in 69 (61%), band ligation in 32 (28%), and sclerotherapy plus band ligation in 13 (11%) cases. Sclerotherapy and cyanoacrylate injection were used for the treatment of gastric varices in 14 (47%) and 16 (53%) cases, respectively. 
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The median time between the two endoscopic attempts to stop the bleeding was 46 (6-120) h. TIPS procedure was performed within 72 h from PHB in 70% of cases and was technically successful in all but seven patients (5%). Eighty patients (55.6%) had uncovered TIPS insertion, while a PTFE-covered stent [GORE ® Viatorr ® (Flagstaff, AZ, USA)] was placed in sixty-four (44.4%). Seventy-six (53%) patients received prophylactic antibiotics (third-generation cephalosporins or, in patients on secondary prophylactic antibiotic therapy with ciprofloxacin for spontaneous bacterial peritonitis, with piperacillin + tazobactam or, prior to its availability, with amoxicillin and clavulanic acid), and all patients received vasoactive drugs prior to endoscopy and TIPS placement. No restrictive blood transfusion policy was applied in this cohort, and patients received blood products with target hemoglobin of 80-100 g/L.
Median follow-up was 116.5 days (range 0-4.164 days). Six-week and 12-month mortalities were 36% and 42%, respectively. Follow-up at 12 months was available for 39 patients (51.3%) of patients who did not reach an endpoint. Death from sepsis occurred in 12 patients: 7 in the group that did not receive antibiotic prophylaxis and 5 in the one receiving antibiotic prophylaxis (p = 0.84).
PPG decreased from a median of 21 mmHg (range 7-48 mmHg) before the shunt to a median of 11 mmHg (1-33 mmHg) post-procedure (p < 0.001). Post-TIPS encephalopathy occurred in 22/144 (15%) patients and was moderate in the majority of cases. All patients with encephalopathy responded to medical treatment, and no stent revision was required. No patient in this cohort experienced heart failure after TIPS insertion.
Re-bleeding
Recurrent bleeding occurred in 42 patients (29%), thirtyfour of whom re-bled from esophageal varices, 5 from portal hypertensive gastropathy, and 3 from other causes (2 ectopic varices and 1 from ulcers of the distal esophagus from prior sclerotherapy, all diagnosed endoscopically). Twenty-three of these patients (23/42, 54.8%) re-bled within 6 weeks from TIPS placement. In 3/23 (13%) patients, rebleeding at 6 weeks was due to failure in achieving a PPG reduction less than 20% and in 3/23 (13%) to concurrent bacterial infection. In 10/23 (43.5%) subjects, re-bleeding at 6 weeks was caused by stent occlusion/stenosis. In the remaining 7/23 (30.5%) cases, the causes of re-bleeding were undetermined. Stent occlusion/stenosis occurred in 18 (12.5%) patients overall, at a median of 146 days after TIPS placement. Re-bleeding related to stent dysfunction was associated with uncovered TIPS in the majority of cases (14/18 patients, 78%, p = 0.018). We included in the study 63 patients with CPS 10-13 and 10 patients with CPS 14-15. Re-bleeding rate was similar in the two groups, occurring in 20 patients (32%) in the CPS 10-13 group and in 3 (30%) of the subjects with a CPS 14-15. Also, there was not statistically significant difference in re-bleeding between the groups of patients receiving or not prophylactic antibiotics (p = 0.821). Univariate logistic regression analysis showed that re-bleeding rate at 6 weeks was related to pre-TIPS PPG, pre-TIPS ITUs, and uncovered versus PTFE stent. Pre-TIPS PPG (OR 1.267, 95% CI 1.032-1.555, p = 0.024) and pre-TIPS ITUs (OR 2.765, 95% CI 1.237-4.398, p = 0.012) were independently associated with re-bleeding at multivariate logistic regression analysis.
Mortality
Models for 6-Week Mortality
The variables significantly associated with 6-week mortality at the univariate analysis (p < 0.05) were bilirubin, creatinine, INR, platelet count, HE, the presence of ascites, CPS, MELD score, pre-TIPS ITUs, MV, and Bureau's criteria (Table 2) .
In order to individualize the main prognostic factors related to mortality at 6 weeks and, in particular, to evaluate the significance of CPS and MELD score or their single components, we estimated different logistic regression models. Although not statistically significant at the univariate analysis, uncovered versus PTFE stent and time to TIPS procedure were included in the models. Due to collinearity with ITUs, MV was not included in the multivariate models.
In the first model (MODEL 1), we included both CPS and MELD score (but not the single components of both scores). The only factor remaining significantly related to 6-week mortality in this multivariate model was pre-TIPS ITUs (OR 3.149, 95% CI 1.422-6.971, p = 0.005 (Table 3) .
In the second model (MODEL 2), CPS was replaced by the CPS individual components (bilirubin, albumin, INR, ascites, HE). Independent predictors of mortality at 6 weeks were pre-TIPS ITUs (OR 3.070, 95% CI 1.313-7.179, p = 0.010), MELD score (OR 1.075, 95% CI 1.017-1.136, p = 0.011), and ascites (OR 2.468, 95% CI 1.010-6.030) ( Table 3 ).
The third model (MODEL 3) evaluated MELD individual components. CPS (OR 1.304, 95% CI 1.076-1.580, p = 0.007) and pre-TIPS ITUs (OR 3.332, 95% CI 1.487-7.466, p = 0.003) were identified as significant predictors of mortality at 6 weeks post-salvage TIPS (Table 3) .
Results did not substantially change when we performed a sub-analysis according to the time of TIPS placement, considering as a time point the year 2002, when covered stents became the gold standard in our center and the use of prophylactic antibiotic therapy became the commonest approach. Notably, MELD score lost its significance in the prediction of 6-week mortality in the group receiving TIPS before 2002. A more advanced age was independently associated with mortality at 6 weeks in the group receiving TIPS after 2002, in all the multivariate analysis models (data not shown).
Models for 12-Month Mortality
Significant variables at the univariate analysis (p < 0.05) for 12-month mortality were bilirubin, creatinine, INR, platelet count, HE, the presence of ascites, CPS, MELD score, pre-TIPS ITUs, MV, and Bureau's criteria ( Table 2) .
The variables statistically significant at the univariate approach were then entered in the multivariate logistic model. Although not significant at the univariate analysis, time to TIPS procedure (< 24 h, 24-72 h, > 72 h) and uncovered versus PTFE stent were included in the multivariate analysis.
Applying the same approach used for the 6-week mortality, we estimated three different logistic regression models in order to individualize the main prognostic factors of mortality at 12 months. Again, due to collinearity with ITUs, MV was not included in the multivariate models.
In the first model (MODEL 1), we included both CPS and MELD scores. In this model, only CPS (OR 1.361, 95% CI 1.086-1.706, p = 0.007) and pre-TIPS ITUs (OR 3.384, 95% CI 1.558-7.351, p = 0.002) were independently associated with mortality (Table 4 ).
The second model (MODEL 2) was aimed to evaluate the significance of CPS single factors; independent predictors of mortality at 12 months were pre-TIPS ITUs (OR 3.549, 95% CI 1.534-8.215, p = 0.003), MELD score (OR 1.058, 95% CI 1.001-1.119, p = 0.046), and the presence of ascites (OR 3.385, 95% CI 1.392-8.234, p = 0.007) ( Table 4 ).
The third model (MODEL 3) evaluated MELD components in relation to 12-month mortality; pre-TIPS ITUs (OR 3.466, 95% CI 1.587-7.573, p = 0.002) and CPS (OR 1.396, 95% CI 1.147-1.698, p = 0.001) were independently associated with mortality (Table 4) . These results did not substantially change when Cox regression model was applied (data not shown). Log-rank test was applied to compare survival between patients in Child-Pugh class of 5-9 (CP-A/B) and patients in Child-Pugh class of 10-15 (CP-C). Overall survival was significantly longer in CP-A/B compared to CP-C (median 334 vs. 48 days, respectively, p = 0.002). A similar significance was found, at the Kaplan-Mayer analysis, for survival at 6 weeks (p = 0.008) and 12 months (p = 0.001) (Fig. 1) . Mortality rate in the 63 patients with CPS 10-13 was of 29.4% at 6 weeks and 65% at 12 months; all 10 patients in CPS 14-15 died within 6 weeks.
Finally, we performed a survival analysis stratifying patients according to Bureau's criteria and time to TIPS placement. At 12 months, patients who met Bureau's criteria had significantly longer survival than those who did not meet them (p = 0.008) (Fig. 2a) . When we evaluated only patients in CP-A/B, this difference was maintained (p = 0.050) (Fig. 2b) , while Bureau's criteria did not influence survival in patients in CP-C (p = 0.891) (Fig. 2c) . No statistically significant difference in survival was found when patients were stratified according to time to TIPS insertion (data not shown). Results did not substantially change when we performed a sub-analysis according to time of TIPS placement (before and after 2002)-data not shown.
Discussion
In this retrospective study of salvage TIPS placement for acute PHB refractory to standard endoscopic treatment, we showed that both low MELD and Child-Pugh score and no ITU stay prior to TIPS are all associated with an improved 6-week survival. No ITU stay was also an important predictor of survival at 12 months, together with a lower Child-Pugh score. Importantly, the use of salvage TIPS was futile for patients with Child-Pugh score of 14-15. In cirrhotic patients with PHB, the standard treatment algorithm based on early vasoactive medications, prophylactic antibiotics, and therapeutic endoscopic procedures has still a 10-20% rate of treatment failure and mortality [15, 21, 22] . Patients with advanced liver disease (Child-Pugh class C or class B with active bleeding at endoscopy) are at higher risk of treatment failure and increased mortality [23] . In such patients, preemptive TIPS performed within 72 h of the PHB leads to a significant reduction of treatment failure, re-bleeding, and mortality rate [3] . The improved outcome due to the use of early TIPS in high-risk patients has been confirmed by two recently published cohort studies [24, 25] . According to these results, both the Baveno VI recommendations and the current UK guidelines suggest considering early preemptive insertion of TIPS in patients with Child-Pugh class C (score of 10-13) or in Child-Pugh class B with active bleeding [23, 26] . Based on the recent cohort studies, selection criteria for early TIPS need further evaluation in dedicated randomized multicenter clinical trials [27] , as patients with Child-Pugh B and active bleeding might not have a survival benefit. The preemptive TIPS strategy aims to reduce the number of patients with refractory variceal bleeding which is associated with a high mortality and would require a salvage TIPS, as we report in the current study.
Herein, we observed a cumulative 1-year mortality of 42%, which is significantly higher than that reported in the two randomized trials by Monescillo et al. [20] and Garcia Pagan et al. [3] . This was expected, as all patients in our cohort had salvage TIPS due to refractory bleeding and not an early TIPS after a successful endoscopic procedure in order to reduce the risk of re-bleeding. In the 30% of cases of our cohort in which TIPS insertion was performed after 72 h from the onset of the bleeding, the delay was due to the fact that these patients were referred to our center from other district hospitals after undergoing two endoscopic attempts to control the hemorrhage. Despite this, with a 6-week rebleeding rate of 16% and a six-week mortality rate of 36%, patients from our cohort had relatively good outcomes when compared with previous reports of salvage TIPS for uncontrollable PH bleeding unresponsive to medical and endoscopic therapy. In the available literature, the incidence of re-bleeding (often reported at 2 weeks) ranges from 6 to 50%, while 30-day mortality rate has been reported between 15 and 60% [28, 29] .
Several prognostic models have been evaluated for patients undergoing emergency TIPS for PHB, with the subsequent development of various scoring systems [28, 30, 31] . In a study aimed at identifying parameters of prognostic value for survival in patients with refractory ascites treated with TIPS, Bureau and colleagues found that a combination of a bilirubin level below 50 μmol/L (3 mg/dl) and a platelet count above 75x10 9 /L is a predictor of mortality within 1 year from the procedure [14] . Herein, we investigated, for the first time, the predictive role of these criteria, patients undergoing salvage TIPS for refractory variceal bleeding. In our setting, these cutoffs were not predictive for 6-week and 12-month mortalities. However, when we stratified patients according to Bureau's criteria, patients who had a platelet count < 75 × 10 9 /L and a total bilirubin > 3 mg/dl had a statistically significant higher mortality rate up to a Child-Pugh score of 9. These criteria lost their utility for stratifying risk in patients who had more advanced disease (CPS 10-15).
Although they have never been validated in urgent/emergency/salvage TIPS, MELD and Child-Pugh (class and score) have been widely and ubiquitously applied in this setting either to stratify patients or to predict risk of treatment failure, re-bleeding, and mortality [3] . Child-Pugh score was originally developed as a model to predict success in portocaval shunt [32] and is nowadays widely utilized. On the contrary, MELD score has been developed to predict short-term survival in patients undergoing elective TIPS [12] . MELD score is widely accepted as the best predictor of early mortality after TIPS. In a large cohort of patients admitted to a specialist liver ITU for acute variceal hemorrhage, MELD score was reported to be even comparable to physiological and organ failure scores in predicting hospital mortality [33] .
In order to investigate the predictive value of CPS and MELD score in salvage TIPS, we constructed three models of multivariate analysis, considering the single components of CPS and MELD scores and comparing the two scores (CPS vs. MELD). In our population, MELD score was an independent predictor of 6-week mortality, in agreement with what was reported in a recent meta-analysis [34] and a recent retrospective study [13] , both concluding that MELD score has the same accuracy in predicting the three-month mortality in patient undergoing emergency TIPS for portal hypertensive hemorrhage as in elective TIPS placement. Mortality at 12 months, instead, was better predicted by the CPS. The reason for this is probably related to the fact that despite that MELD score, as a result of a mathematical calculation based on biochemical parameters, is a more objective tool, it might underestimate the risk of death, since it does not take into consideration factors such as HE and ascites, which reflect a more advanced liver disease and are known to have a strong impact on patients survival [34, 35] .
Since CPS 14-15 was one of the exclusion criteria for the early-TIPS trial [3] , we wanted to evaluate re-bleeding and mortality rate in this subgroup of patients. In our cohort, none of the patients in CPS 14-15 survived at 30 days, confirming the futility of a treatment with TIPS in patients with severely decompensated disease.
Hemodynamic parameters expressed by PPG measurements allow a good risk stratification of patients at high risk of treatment failure [20] . PPG is considered the only predictive factor of short-and long-term mortalities as well as of re-bleeding in patients who do not reach a target portal pressure reduction of ≥ 20% from baseline or a value of PPG ≤ 12 mmHg after TIPS placement [20, 36] . However, PPG is not widely available and may be difficult to be performed early (i.e., within 24 h) in bleeding patients. In our series, re-bleeding within 6 weeks (TIPS failure) was related to pre-TIPS PPG in both CPS classes.
Pre-TIPS intensive care unit stay was the second factor related to TIPS failure in our cohort. Furthermore, ITU stay before the procedure was a strong independent predictor of both short-and long-term mortality. Need of ITU support before the TIPS procedure was in fact associated with a three-and fivefold increased risk of death at 6 weeks and 12 months, respectively. Cirrhotic patients often develop complications such as grade III-IV HE, septic shock, and variceal bleeding which require intensive care support for invasive monitoring and airway protection. Short-term prognosis in cirrhotic patients who develop multiple organ dysfunction, including refractory circulatory failure, remains poor despite ITU support, with most deaths occurring during the first week from admission [37, 38] .
The use of PTFE-coated stents has reduced the occurrence of complications related to shunt dysfunction such as bleeding episodes consequent to occlusion. In our cohort, despite the fact that the use of coated stent did not result in a survival advantage, in keeping with the results of a recent randomized controlled trial [39] , the rate of occlusion and, subsequently, the rate of re-bleeding were significantly lower for the PTFE-covered stents than for the bare ones.
Limitations of this study include its retrospective nature, the inclusion of patients over a long period with changes in the standard of care, and the fact that most of the patients were referred to our center from other hospitals. As a result, there is lack of complete data on pre-TIPS care such as the use of balloon tamponade and renal replacement therapy, as well as details on post-TIPS infective episodes. The inclusion of a substantial proportion of patients that did not receive the current standards (covered TIPS and prophylactic antibiotics) could raise concerns regarding the applicability of this analysis to current patients being treated with emergency TIPS. However, the sensitivity analysis in patients receiving the current standard of care confirmed that the proposed models are still valid in this subpopulation.
In conclusion, according to our findings, MELD score seems to be a reliable predictor of short-term mortality in patients with refractory PHB undergoing salvage TIPS, whose long-term follow-up is greatly influenced by the stage of liver disease and its complications and therefore by CPS. Bureau's criteria have a potentially good prognostic value for 1-year survival in patients with Child-Pugh A and B. Severity of clinical condition at the time of TIPS placement and the need of intensive care support greatly influence patients' outcome. The combined use of prognostic scores applied in critically ill patients and MELD score should be considered in the attempt to stratify this high-risk population and to identify which ones may benefit from salvage TIPS. Furthermore, our results show that salvage TIPS placement for acute PHB should be avoided in patients with severely decompensated liver disease (CPS [14] [15] , in view of the universal short-term mortality of this group despite intensive care management and salvage TIPS placement.
Compliance with ethical standards
Conflict of interest The authors who have taken part in this study do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Ethical approval This was a single-center retrospective audit including consecutive patients with cirrhosis and variceal bleeding admitted at the Royal Free Hospital who underwent TIPS placement. As such, ethical approval and consent was not required.
